Israel and the Delta variant: what we know so far

A rise in virus cases in Israel has prompted the government to re-impose restrictions on activity, including mask mandates and vaccine certification for large events. There are signs that the Pfizer vaccine may be much less effective at preventing infection against the Delta variant and that vaccine efficacy fades over time, prompting the introduction of booster jabs. So far there is little evidence to suggest that the vaccine is much less effective at preventing severe illness. While the re-opening of international tourism is likely to be delayed, restrictions on the domestic economy look set to remain light-touch.